Palomar entering skin resurfacing laser market with Tissue Technologies buy.
This article was originally published in The Gray Sheet
Executive SummaryPALOMAR PLANS TO ENTER SKIN RESURFACING LASER MARKET VIA ACQUISITION of Tissue Technologies, Inc. outlined in an agreement in principle signed Feb. 9. Privately held Tissue Technologies said the stock swap acquisition is valued in the $20-30 mil. range. Specific terms of the deal, expected to close by mid- March, were not disclosed.
You may also be interested in...
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
Hikma and Civica Rx have announced the launch of a first wave of eight essential injectable medicines, including heparin, as part of a deal struck between the two firms earlier this year.